Statoil ASA: Allocation of Dividend Shares to primary insiders
/
Date22 Sep 2016
STAVANGER, Norway, Sept. 22, 2016 (GLOBE NEWSWIRE) — Reference is made to the announcement by Statoil ASA (the “Company”, OSE:STL, NYSE:STO) on 23 May 2016... Read More →
Statoil ASA: Allocation of Dividend Shares to primary insiders
/
Date22 Sep 2016
STAVANGER, Norway, Sept. 22, 2016 (GLOBE NEWSWIRE) — Reference is made to the announcement by Statoil ASA (the “Company”, OSE:STL, NYSE:STO) on 23 May 2016... Read More →
CGG: Completes Phase 1 Processing for Davros Multi-Client Survey in Northern Carnarvon Basin
/
Date22 Sep 2016
PARIS, Sept. 22, 2016 (GLOBE NEWSWIRE) — CGG announced today that the final pre-stack depth-migrated data for Phase 1 of its Davros 3D BroadSeis(TM) and... Read More →
Nicox first half 2016 business and financial update
/
Date22 Sep 2016
Latanoprostene bunod licensee Bausch + Lomb receives Complete Response Letter from U.S. FDA pertaining to B+L manufacturing facility; no efficacy or safety concerns or additional... Read More →
TiGenix Appoints Dr. June Almenoff to its Board of Directors
/
Date22 Sep 2016
LEUVEN, Belgium, Sept. 22, 2016 (GLOBE NEWSWIRE) — TiGenix NV (Euronext Brussels: TIG), an advanced biopharmaceutical company focused on developing and commercializing novel therapeutics from... Read More →
Amgen (AMGN) Repatha Meets Endpoints in Phase III Study
/
Date22 Sep 2016
Amgen, Inc. AMGN announced positive top-line results from a phase III study evaluating the effect of its cholesterol-lowering medication, Repatha (evolocumab), in patients with coronary... Read More →